Corrigendum to “(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation” [Int. Immunopharmacol. 125(Part B) (2023) 111124] (International Immunopharmacology (2023) 125(PA), (S1567576923014509), (10.1016/j.intimp.2023.111124))

Boyoung Kim, Ji Eun Yu, In Jun Yeo, Dong Ju Son, Hee Pom Lee, Yoon Seok Roh, Key Hwan Lim, Jaesuk Yun, Hanseul Park, Sang Bae Han, Jin Tae Hong

Research output: Contribution to journalComment/debate

Abstract

The authors regret that an error was identified in Fig. 3(C) of the manuscript. The low magnification images for iNOS and COX-2 were incorrectly presented as identical. We would like to replace the incorrect low magnification image for COX-2 with the correct one.[Formula presented] The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number112543
JournalInternational Immunopharmacology
Volume137
DOIs
StatePublished - 20 Aug 2024

Fingerprint

Dive into the research topics of 'Corrigendum to “(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation” [Int. Immunopharmacol. 125(Part B) (2023) 111124] (International Immunopharmacology (2023) 125(PA), (S1567576923014509), (10.1016/j.intimp.2023.111124))'. Together they form a unique fingerprint.

Cite this